{"entity":{"type":"insider","cik":"0001829069","url":"/insider/0001829069","json_url":"/insider/0001829069.json","name":"Sanna Bastiano","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":63,"n_filings":21,"first":"2021-02-16","last":"2023-05-09","span_basis":"filed_date"},"name_variants":[{"name":"Sanna Bastiano","source":"filing","n_filings":21,"first_seen":"2021-02-16","last_seen":"2023-05-09"}],"transactions":[{"id":7950635,"accession":"0001209191-23-028243","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-028243","line_url":"/filing/0001209191-23-028243#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001829069","owner_name":"Sanna Bastiano","owner_display_name":"Sanna Bastiano","owner_url":"/insider/0001829069","role":"Officer (EVP, Cell & Genetic Therapies)","role_mark":"O","role_mark_label":"Officer (EVP, Cell & Genetic Therapies)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Cell & Genetic Therapies","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2850.0,"shares_display":"2,850","price_per_share":350.0,"price_display":"350.00","price_state":"stated","total_value":997500.0,"total_display":"997,500.00","total_whole":"997,500","shares_owned_after":32038.0,"shares_owned_after_display":"32,038","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-08","filed_date":"2023-05-09","scope":"insider"},{"id":7950632,"accession":"0001209191-23-028243","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-028243","line_url":"/filing/0001209191-23-028243#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001829069","owner_name":"Sanna Bastiano","owner_display_name":"Sanna Bastiano","owner_url":"/insider/0001829069","role":"Officer (EVP, Cell & Genetic Therapies)","role_mark":"O","role_mark_label":"Officer (EVP, Cell & Genetic Therapies)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Cell & Genetic Therapies","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":422.0,"shares_display":"422","price_per_share":350.03,"price_display":"350.03","price_state":"stated","total_value":147712.66,"total_display":"147,712.66","total_whole":"147,713","shares_owned_after":34888.0,"shares_owned_after_display":"34,888","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-05","filed_date":"2023-05-09","scope":"insider"},{"id":8371229,"accession":"0001209191-23-027374","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-23-027374","line_url":"/filing/0001209191-23-027374","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001829069","owner_name":"Sanna Bastiano","owner_display_name":"Sanna Bastiano","owner_url":"/insider/0001829069","role":"Officer (EVP, Cell & Genetic Therapies)","role_mark":"O","role_mark_label":"Officer (EVP, Cell & Genetic Therapies)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Cell & Genetic Therapies","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2781.0,"shares_display":"2,781","price_per_share":350.74366055375765,"price_display":"350.74","price_state":"stated","total_value":975418.12,"total_display":"975,418.12","total_whole":"975,418","shares_owned_after":36038.0,"shares_owned_after_display":"36,038","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-03","filed_date":"2023-05-04","scope":"insider","n_lines":2},{"id":8371222,"accession":"0001209191-23-027374","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-027374","line_url":"/filing/0001209191-23-027374","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001829069","owner_name":"Sanna Bastiano","owner_display_name":"Sanna Bastiano","owner_url":"/insider/0001829069","role":"Officer (EVP, Cell & Genetic Therapies)","role_mark":"O","role_mark_label":"Officer (EVP, Cell & Genetic Therapies)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Cell & Genetic Therapies","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1622.0,"shares_display":"1,622","price_per_share":350.6586806411837,"price_display":"350.66","price_state":"stated","total_value":568768.38,"total_display":"568,768.38","total_whole":"568,768","shares_owned_after":38302.0,"shares_owned_after_display":"38,302","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-02","filed_date":"2023-05-04","scope":"insider","n_lines":3},{"id":7997809,"accession":"0001209191-23-024312","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-024312","line_url":"/filing/0001209191-23-024312","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001829069","owner_name":"Sanna Bastiano","owner_display_name":"Sanna Bastiano","owner_url":"/insider/0001829069","role":"Officer (EVP, Cell & Genetic Therapies)","role_mark":"O","role_mark_label":"Officer (EVP, Cell & Genetic Therapies)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Cell & Genetic Therapies","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7567.0,"shares_display":"7,567","price_per_share":326.7033368574072,"price_display":"326.70","price_state":"stated","total_value":2472164.15,"total_display":"2,472,164.15","total_whole":"2,472,164","shares_owned_after":42338.0,"shares_owned_after_display":"42,338","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-12","filed_date":"2023-04-14","scope":"insider","n_lines":3},{"id":8106851,"accession":"0001209191-23-023588","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-23-023588","line_url":"/filing/0001209191-23-023588","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001829069","owner_name":"Sanna Bastiano","owner_display_name":"Sanna Bastiano","owner_url":"/insider/0001829069","role":"Officer (EVP, Cell & Genetic Therapies)","role_mark":"O","role_mark_label":"Officer (EVP, Cell & Genetic Therapies)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Cell & Genetic Therapies","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":522.0,"shares_display":"522","price_per_share":315.81291187739464,"price_display":"315.81","price_state":"stated","total_value":164854.34,"total_display":"164,854.34","total_whole":"164,854","shares_owned_after":47591.0,"shares_owned_after_display":"47,591","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-04","filed_date":"2023-04-06","scope":"insider","n_lines":5},{"id":8575044,"accession":"0001209191-23-020043","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-020043","line_url":"/filing/0001209191-23-020043","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001829069","owner_name":"Sanna Bastiano","owner_display_name":"Sanna Bastiano","owner_url":"/insider/0001829069","role":"Officer (EVP, Cell & Genetic Therapies)","role_mark":"O","role_mark_label":"Officer (EVP, Cell & Genetic Therapies)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Cell & Genetic Therapies","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2746.0,"shares_display":"2,746","price_per_share":300.5909541150765,"price_display":"300.59","price_state":"stated","total_value":825422.76,"total_display":"825,422.76","total_whole":"825,423","shares_owned_after":49532.0,"shares_owned_after_display":"49,532","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-16","filed_date":"2023-03-20","scope":"insider","n_lines":2},{"id":8182697,"accession":"0001209191-23-010055","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-010055","line_url":"/filing/0001209191-23-010055","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001829069","owner_name":"Sanna Bastiano","owner_display_name":"Sanna Bastiano","owner_url":"/insider/0001829069","role":"Officer (EVP, Cell & Genetic Therapies)","role_mark":"O","role_mark_label":"Officer (EVP, Cell & Genetic Therapies)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Cell & Genetic Therapies","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2181.0,"shares_display":"2,181","price_per_share":300.3948968363136,"price_display":"300.39","price_state":"stated","total_value":655161.27,"total_display":"655,161.27","total_whole":"655,161","shares_owned_after":60013.0,"shares_owned_after_display":"60,013","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-14","filed_date":"2023-02-16","scope":"insider","n_lines":2},{"id":8543214,"accession":"0001209191-23-009232","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-009232","line_url":"/filing/0001209191-23-009232#line-3","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001829069","owner_name":"Sanna Bastiano","owner_display_name":"Sanna Bastiano","owner_url":"/insider/0001829069","role":"Officer (EVP, Cell & Genetic Therapies)","role_mark":"O","role_mark_label":"Officer (EVP, Cell & Genetic Therapies)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Cell & Genetic Therapies","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":113.0,"shares_display":"113","price_per_share":300.39,"price_display":"300.39","price_state":"stated","total_value":33944.07,"total_display":"33,944.07","total_whole":"33,944","shares_owned_after":61915.0,"shares_owned_after_display":"61,915","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-13","filed_date":"2023-02-14","scope":"insider"},{"id":8182577,"accession":"0001209191-23-006215","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-006215","line_url":"/filing/0001209191-23-006215#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001829069","owner_name":"Sanna Bastiano","owner_display_name":"Sanna Bastiano","owner_url":"/insider/0001829069","role":"Officer (EVP, Cell & Genetic Therapies)","role_mark":"O","role_mark_label":"Officer (EVP, Cell & Genetic Therapies)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Cell & Genetic Therapies","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":106.0,"shares_display":"106","price_per_share":325.0,"price_display":"325.00","price_state":"stated","total_value":34450.0,"total_display":"34,450.00","total_whole":"34,450","shares_owned_after":37998.0,"shares_owned_after_display":"37,998","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-31","filed_date":"2023-02-02","scope":"insider"},{"id":6767894,"accession":"0000899243-22-034883","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000899243-22-034883","line_url":"/filing/0000899243-22-034883","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001829069","owner_name":"Sanna Bastiano","owner_display_name":"Sanna Bastiano","owner_url":"/insider/0001829069","role":"Officer (EVP, Cell & Genetic Therapies)","role_mark":"O","role_mark_label":"Officer (EVP, Cell & Genetic Therapies)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Cell & Genetic Therapies","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":320.0,"shares_display":"320","price_per_share":312.6409375,"price_display":"312.64","price_state":"stated","total_value":100045.1,"total_display":"100,045.10","total_whole":"100,045","shares_owned_after":38229.0,"shares_owned_after_display":"38,229","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-02","filed_date":"2022-11-03","scope":"insider","n_lines":7},{"id":6561062,"accession":"0000899243-22-033880","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-033880","line_url":"/filing/0000899243-22-033880","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001829069","owner_name":"Sanna Bastiano","owner_display_name":"Sanna Bastiano","owner_url":"/insider/0001829069","role":"Officer (EVP, Cell & Genetic Therapies)","role_mark":"O","role_mark_label":"Officer (EVP, Cell & Genetic Therapies)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Cell & Genetic Therapies","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1791.0,"shares_display":"1,791","price_per_share":300.3126633165829,"price_display":"300.31","price_state":"stated","total_value":537859.98,"total_display":"537,859.98","total_whole":"537,860","shares_owned_after":39480.0,"shares_owned_after_display":"39,480","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-18","filed_date":"2022-10-20","scope":"insider","n_lines":2},{"id":6139938,"accession":"0000899243-22-018605","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-22-018605","line_url":"/filing/0000899243-22-018605","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001829069","owner_name":"Sanna Bastiano","owner_display_name":"Sanna Bastiano","owner_url":"/insider/0001829069","role":"Officer (EVP, Cell & Genetic Therapies)","role_mark":"O","role_mark_label":"Officer (EVP, Cell & Genetic Therapies)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Cell & Genetic Therapies","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45.0,"shares_display":"45","price_per_share":252.828,"price_display":"252.83","price_state":"stated","total_value":11377.26,"total_display":"11,377.26","total_whole":"11,377","shares_owned_after":41757.0,"shares_owned_after_display":"41,757","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-16","filed_date":"2022-05-18","scope":"insider","n_lines":5},{"id":6263891,"accession":"0000899243-22-017086","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-017086","line_url":"/filing/0000899243-22-017086#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001829069","owner_name":"Sanna Bastiano","owner_display_name":"Sanna Bastiano","owner_url":"/insider/0001829069","role":"Officer (EVP, Cell & Genetic Therapies)","role_mark":"O","role_mark_label":"Officer (EVP, Cell & Genetic Therapies)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Cell & Genetic Therapies","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36.0,"shares_display":"36","price_per_share":275.09,"price_display":"275.09","price_state":"stated","total_value":9903.24,"total_display":"9,903.24","total_whole":"9,903","shares_owned_after":41660.0,"shares_owned_after_display":"41,660","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-04","filed_date":"2022-05-06","scope":"insider"},{"id":6645232,"accession":"0000899243-22-016641","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000899243-22-016641","line_url":"/filing/0000899243-22-016641","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001829069","owner_name":"Sanna Bastiano","owner_display_name":"Sanna Bastiano","owner_url":"/insider/0001829069","role":"Officer (EVP, Cell & Genetic Therapies)","role_mark":"O","role_mark_label":"Officer (EVP, Cell & Genetic Therapies)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Cell & Genetic Therapies","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":320.0,"shares_display":"320","price_per_share":259.15540625,"price_display":"259.16","price_state":"stated","total_value":82929.73,"total_display":"82,929.73","total_whole":"82,930","shares_owned_after":41906.0,"shares_owned_after_display":"41,906","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-02","filed_date":"2022-05-04","scope":"insider","n_lines":7},{"id":6088430,"accession":"0000899243-22-014360","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-014360","line_url":"/filing/0000899243-22-014360","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001829069","owner_name":"Sanna Bastiano","owner_display_name":"Sanna Bastiano","owner_url":"/insider/0001829069","role":"Officer (EVP, Cell & Genetic Therapies)","role_mark":"O","role_mark_label":"Officer (EVP, Cell & Genetic Therapies)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Cell & Genetic Therapies","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":561.0,"shares_display":"561","price_per_share":276.1764171122995,"price_display":"276.18","price_state":"stated","total_value":154934.97,"total_display":"154,934.97","total_whole":"154,935","shares_owned_after":42812.0,"shares_owned_after_display":"42,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-07","filed_date":"2022-04-08","scope":"insider","n_lines":3},{"id":6691113,"accession":"0000899243-22-014120","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-014120","line_url":"/filing/0000899243-22-014120#line-3","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001829069","owner_name":"Sanna Bastiano","owner_display_name":"Sanna Bastiano","owner_url":"/insider/0001829069","role":"Officer (EVP, Cell & Genetic Therapies)","role_mark":"O","role_mark_label":"Officer (EVP, Cell & Genetic Therapies)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Cell & Genetic Therapies","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3163.0,"shares_display":"3,163","price_per_share":275.23,"price_display":"275.23","price_state":"stated","total_value":870552.49,"total_display":"870,552.49","total_whole":"870,552","shares_owned_after":43343.0,"shares_owned_after_display":"43,343","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-05","filed_date":"2022-04-06","scope":"insider"},{"id":6691112,"accession":"0000899243-22-014120","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-014120","line_url":"/filing/0000899243-22-014120","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001829069","owner_name":"Sanna Bastiano","owner_display_name":"Sanna Bastiano","owner_url":"/insider/0001829069","role":"Officer (EVP, Cell & Genetic Therapies)","role_mark":"O","role_mark_label":"Officer (EVP, Cell & Genetic Therapies)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Cell & Genetic Therapies","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":562.0,"shares_display":"562","price_per_share":267.7082028469751,"price_display":"267.71","price_state":"stated","total_value":150452.01,"total_display":"150,452.01","total_whole":"150,452","shares_owned_after":46763.0,"shares_owned_after_display":"46,763","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-04","filed_date":"2022-04-06","scope":"insider","n_lines":2},{"id":6318123,"accession":"0000899243-22-011701","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-011701","line_url":"/filing/0000899243-22-011701#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001829069","owner_name":"Sanna Bastiano","owner_display_name":"Sanna Bastiano","owner_url":"/insider/0001829069","role":"Officer (EVP, Cell & Genetic Therapies)","role_mark":"O","role_mark_label":"Officer (EVP, Cell & Genetic Therapies)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Cell & Genetic Therapies","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2122.0,"shares_display":"2,122","price_per_share":250.06,"price_display":"250.06","price_state":"stated","total_value":530627.32,"total_display":"530,627.32","total_whole":"530,627","shares_owned_after":48412.0,"shares_owned_after_display":"48,412","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-17","filed_date":"2022-03-21","scope":"insider"}],"collapsed":true,"next_cursor":"2022-03-17|6318123","ledger_fault":false,"count":{"value":63,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":63,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":63},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000875320","name":"VERTEX PHARMACEUTICALS INC / MA","url":"/issuer/0000875320","role":"Officer (EVP, Cell & Genetic Therapies)","n_filings":21,"first_seen":"2021-02-16","last_seen":"2023-05-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001829069","retrieved_at":"2026-08-25T19:35:14+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}